The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.PENNYMAC FINANCIAL SERVICES I
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.NAUTILUS, INC. (NLS)
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.TURKCELL ILETISIM HIZME
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.NAUTILUS, INC. (NLS) is a small-cap growth stock in the Recreati
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative st
Wayfair (NYSE: W) recently gave investors a lot to feel excited about. The furniture and home goods e-commerce company maintained an explosive sales growth pace even as the impact from COVID-19 closures and federal stimulus assistance waned. Wayfair management lifted its 2020 out
Shares of Pfizer (NYSE: PFE) have been on the move since the company announced promising clinical trial results for BNT162b2, a coronavirus vaccine candidate the company is developing in partnership with BioNTech (NASDAQ: BNTX). It looks like the significant investment Pfizer mad
The Canadian marijuana cultivator Aphria (NASDAQ: APHA) satisfied investors with its latest earnings report, growing its net revenue by 16% from the same quarter last year. Between the company's ongoing efforts to drive down the cost of each gram of cannabis sold and maintain its
ExxonMobil (NYSE: XOM) is unquestionably in a tight spot as the coronavirus pandemic has sucked demand out of the energy sector. Revenue has tumbled, profits narrowed, capital expenditures have reduced, and job cuts have been announced.One thing that hasn't been touched, however,
Nearly one-quarter (22%) of retirees say they have Social Security regrets, according to a 2019 study conducted by the Michigan Retirement and Disability Research Center at the University of Michigan.Because Social Security benefits are an integral aspect of retirement for millio
Spotify (NYSE: SPOT) has been on a podcast shopping spree since 2019, spending hundreds of millions of dollars on exclusive content deals and software to help people create and host new podcasts. Most recently, it made a deal to acquire Megaphone for $235 million.The move will ac
This has been a tumultuous year for Wall Street and investors. Though the stock market is always volatile, the coronavirus disease 2019 (COVID-19) pandemic has whipsawed equities like few events we've seen before it. It took less than five weeks for the broad-based S&P 500 to
As of Tuesday, there have been more than 50.9 million confirmed cases of the novel coronavirus worldwide, and 1.26 million deaths. In the U.S. alone, researchers estimate that the total economic impact (healthcare costs, lost productivity from lockdowns and quarantines, travel d
(RTTNews) - European stocks rose for the third straight session on Wednesday as growing hopes that a Covid-19 vaccine is within reach helped investors shrug off concerns regarding the tightening of measures amid the second wave of infections sweeping through Europe.The pan Europe
(RTTNews) - U.K. stocks eked out modest gains on Wednesday as growing hopes that a Covid-19 vaccine is within reach helped investors shrug off concerns regarding the tightening of measures amid the second wave of infections sweeping through Europe. The benchmark FTSE 100 rose 22